SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Natasha M. Archer, Renata Parada Amorim, Rafaela Naves, Simone Hettmer, Lisa R. Diller, Karina Braga Ribeiro, Carlos Rodriguez-Galindo, An increased risk of second malignant neoplasms after rhabdomyosarcoma: Population-based evidence for a cancer predisposition syndrome?, Pediatric Blood & Cancer, 2015, 62, 9
  2. 2
    Simone Hettmer, Roderick T. Bronson, Amy J. Wagers, Distinct Malignant Behaviors of Mouse Myogenic Tumors Induced by Different Oncogenetic Lesions, Frontiers in Oncology, 2015, 5,

    CrossRef

  3. 3
    Philip J. Lupo, Heather E. Danysh, Sharon E. Plon, Karen Curtin, David Malkin, Simone Hettmer, Douglas S. Hawkins, Stephen X. Skapek, Logan G. Spector, Karin Papworth, Beatrice Melin, Erik B. Erhardt, Seymour Grufferman, Joshua D. Schiffman, Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database, Cancer Medicine, 2015, 4, 5
  4. 4
    Yuwen Xie, Peizhi Zong, Weiwei Wang, Dong Liu, Bingcheng Li, Yuanyuan Wang, Jianming Hu, Yan Ren, Yan Qi, Xiaobin Cui, Yunzhao Chen, Chunxia Liu, Feng Li, Hypermethylation of potential tumor suppressor miR-34b/c is correlated with late clinical stage in patients with soft tissue sarcomas, Experimental and Molecular Pathology, 2015, 98, 3, 446

    CrossRef

  5. 5
    Mandy L. Ballinger, Gillian Mitchell, David M. Thomas, Surveillance recommendations for patients with germline TP53 mutations, Current Opinion in Oncology, 2015, 27, 4, 332

    CrossRef

  6. 6
    Kami Wolfe Schneider, Kory Jasperson, Unique Genetic Counseling Considerations in the Pediatric Oncology Setting, Current Genetic Medicine Reports, 2015, 3, 2, 65

    CrossRef

  7. You have free access to this content7
    Junne Kamihara, Huma Q. Rana, Judy E. Garber, Germline TP53 Mutations and the Changing Landscape of Li–Fraumeni Syndrome, Human Mutation, 2014, 35, 6